Bios Partners — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
BiotechHummelstown, US
Stephen C. Rocamboli(Executive Officer, Director)Rifat Pamukcu(Director)Robert Towarnicki(Executive Officer, Director)Roger Sawhney(Director)
BoardJohn Fucci(Director)
Board seatTim Van Treuren· per SEC Form D · $42.1M raise · filed Jan 2024
Preclinical biotech developing first-in-class treatments for serious neurodegenerative disorders such as stroke, using its engineered perlecan domain V.
BiotechHouston, US
Chris Garabedian(Director)William Schwieterman(Executive Officer, Director)Fred Callori(Director)
BoardAmanda De La Garza(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.